Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients (Q35840025)

10 August 2017

1 reference

title

Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients (English)

1 reference

10 August 2017

2

Klaus V Toyka

1 reference

10 August 2017

Rudolf Martini

1

1 reference

10 August 2017

language of work or name

1 reference

1 August 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

3

1 reference

10 August 2017

issue

8

1 reference

10 August 2017

page(s)

457-465

1 reference

Genetic and clinical aspects of Charcot-Marie-Tooth's disease

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Disease mechanisms and potential therapeutic strategies in Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

The causes of Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Hereditary motor and sensory neuropathies: a biological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Biology and Genetics of Hereditary Motor and Sensory Neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

A transgenic rat model of Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Mutations in the cytoplasmic domain of P0 reveal a role for PKC-mediated phosphorylation in adhesion and myelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Charcot–Marie–Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

De novo mutation of the myelin P0 gene in Dejerine-Sottas disease (hereditary motor and sensory neuropathy type III)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Structure and chromosomal localization of the gene encoding the human myelin protein zero (MPZ)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Mutation of the myelin Po gene in Charcot — Marie — Tooth neuropathy type 1B

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Deletion of the serine 34 codon from the major peripheral myelin protein P0 gene in Charcot-Marie-Tooth disease type 1B

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axons.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Connexin mutations in X-linked Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Connexin32 is a myelin-related protein in the PNS and CNS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Functional gap junctions in the schwann cell myelin sheath

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Structural abnormalities and deficient maintenance of peripheral nerve myelin in mice lacking the gap junction protein connexin 32

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Connexin32-null mice develop demyelinating peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Global ischemia-induced increases in the gap junctional proteins connexin 32 (Cx32) and Cx36 in hippocampus and enhanced vulnerability of Cx32 knock-out mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Chronic inflammatory demyelinating polyneuropathy or hereditary motor and sensory neuropathy? Diagnostic value of morphological criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Major histocompatibility complex class II expression and macrophage responses in genetically proven Charcot-Marie-Tooth type 1 and hereditary neuropathy with liability to pressure palsies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Bone marrow transfer from wild-type mice reverts the beneficial effect of genetically mediated immune deficiency in myelin mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Electron microscope observations on demyelination and remyelination in experimental allergic neuritis. I. Demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Origin of pathogenic macrophages and endoneurial fibroblast-like cells in an animal model of inherited neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Mechanisms of immune regulation in the peripheral nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Functional significance of the perforin/granzyme cell death pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Animal models for inherited peripheral neuropathies.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Occurrence of active demyelinating lesions in children with hereditary motor and sensory neuropathy (HMSN) type I

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Chronic inflammatory demyelinating polyneuropathy caused by HIV infection in a patient with asymptomatic CMT 1A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Corticosteroid- responsive asymmetric neuropathy with a myelin protein zero gene mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Inflammatory demyelination in a patient with CMT1A.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Coexistent hereditary and inflammatory neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Corticosteroid-responsive dominantly inherited neuropathy in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Acute inflammatory neuropathy in Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Sensory manifestations in Charcot-Marie-Tooth disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Inflammation and neuropathic attacks in hereditary brachial plexus neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

The pathogenesis of CIDP: rationale for treatment with immunomodulatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Coexistence of hereditary motor and sensory neuropathy type Ia and IgM paraproteinemic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Tolerance induction by intrathymic expression of P0.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Promiscuous gene expression and central T-cell tolerance: more than meets the eye.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Epitope spreading in immune-mediated diseases: implications for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Impaired sensory function in heterozygous P0 knockout mice is associated with nodal changes in sensory nerves

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900822-1

7 January 2021

10.1016/S1474-4422(04)00822-1

Identifiers

DOI

1 reference

10 August 2017

1 reference